These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10961420)

  • 1. Toxic effector molecules in the pathogenesis of immune-mediated disorders of the central nervous system.
    Kieseier BC; Storch MK; Hartung HP
    J Neural Transm Suppl; 2000; 59():69-80. PubMed ID: 10961420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory mediators in demyelinating disorders of the CNS and PNS.
    Hartung HP; Jung S; Stoll G; Zielasek J; Schmidt B; Archelos JJ; Toyka KV
    J Neuroimmunol; 1992 Oct; 40(2-3):197-210. PubMed ID: 1331168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement components of the innate immune system in health and disease in the CNS.
    Gasque P; Dean YD; McGreal EP; VanBeek J; Morgan BP
    Immunopharmacology; 2000 Aug; 49(1-2):171-86. PubMed ID: 10904116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.
    Merson TD; Binder MD; Kilpatrick TJ
    Neuromolecular Med; 2010 Jun; 12(2):99-132. PubMed ID: 20411441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in the CNS: balance between immunological privilege and immune responses.
    Matyszak MK
    Prog Neurobiol; 1998 Oct; 56(1):19-35. PubMed ID: 9723129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuro-immune crosstalk in CNS diseases.
    Kerschensteiner M; Meinl E; Hohlfeld R
    Results Probl Cell Differ; 2010; 51():197-216. PubMed ID: 19343310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of IL-15 in central nervous system disorders.
    Rentzos M; Rombos A
    Acta Neurol Scand; 2012 Feb; 125(2):77-82. PubMed ID: 21615353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemokine system in neuroinflammation: an update.
    Ransohoff RM
    J Infect Dis; 2002 Dec; 186 Suppl 2():S152-6. PubMed ID: 12424691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nitric oxide and reactive oxygen species in arthritis.
    Cuzzocrea S
    Curr Pharm Des; 2006; 12(27):3551-70. PubMed ID: 17017948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease.
    Scarisbrick IA
    Curr Top Microbiol Immunol; 2008; 318():133-75. PubMed ID: 18219817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the role of Toll-like receptors in diseases of the central nervous system.
    Carty M; Bowie AG
    Biochem Pharmacol; 2011 Apr; 81(7):825-37. PubMed ID: 21241665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The many faces of EMMPRIN - roles in neuroinflammation.
    Agrawal SM; Yong VW
    Biochim Biophys Acta; 2011 Feb; 1812(2):213-9. PubMed ID: 20674741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement in neurobiology.
    Horstman LL; Jy W; Ahn YS; Maghzi AH; Etemadifar M; Alexander JS; McGee JC; Minagar A
    Front Biosci (Landmark Ed); 2011 Jun; 16(8):2921-60. PubMed ID: 21622213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system.
    Hartung HP; Kieseier BC
    J Neuroimmunol; 2000 Jul; 107(2):140-7. PubMed ID: 10854648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update on the Role of Matrix Metalloproteinases in the Pathogenesis of Multiple Sclerosis.
    Boziki M; Grigoriadis N
    Med Chem; 2018 Feb; 14(2):155-169. PubMed ID: 28875862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-arginine and nitric oxide in CNS function and neurodegenerative diseases.
    Virarkar M; Alappat L; Bradford PG; Awad AB
    Crit Rev Food Sci Nutr; 2013; 53(11):1157-67. PubMed ID: 24007420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.
    Cuzner ML; Opdenakker G
    J Neuroimmunol; 1999 Feb; 94(1-2):1-14. PubMed ID: 10376931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of immune-mediated demyelination in the CNS.
    Hartung HP; Rieckmann P
    J Neural Transm Suppl; 1997; 50():173-81. PubMed ID: 9120417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuro-immune crosstalk in CNS diseases.
    Kerschensteiner M; Meinl E; Hohlfeld R
    Neuroscience; 2009 Feb; 158(3):1122-32. PubMed ID: 18848864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.